1AD 4.00% 2.4¢ adalta limited

It is simple. This is yet another biotech that listed too early,...

  1. 43 Posts.
    lightbulb Created with Sketch. 33
    It is simple. This is yet another biotech that listed too early, talks big then but fails to execute and misses milestones..

    The IPO presentation said they would "partner their lead candidate in CY2018."

    https://www.asx.com.au/asxpdf/20160822/pdf/439hc66h4bflyk.pdf

 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.